CIK: 1702031 - Address: 2200 Pennsylvania Avenue Nw Suite 300E, Washington, DC 20037
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/6/24 16:46
3/4/24
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.m-734.210-17-5314D
3/6/23 18:24
3/2/23
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.m-1056.230-17-8206D
8/29/22 17:02
8/26/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiM.d43.12011190D
3/2/22 21:26
3/1/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.dm-17511.250-16-8189D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact